<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ADMET-Screening on Bioecon</title><link>https://en.bioecon.ru/technologies/admet-screening/</link><description>Recent content in ADMET-Screening on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 22 Jul 2026 21:55:35 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/admet-screening/index.xml" rel="self" type="application/rss+xml"/><item><title>Toxics screening (toxicomics, service)</title><link>https://en.bioecon.ru/technology/toxics-screening-toxicomics-service/</link><pubDate>Wed, 22 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/toxics-screening-toxicomics-service/</guid><description>Contract safety assessment that takes a drug candidate from in-silico ADMET triage through in-vitro panels (hepatotoxicity, hERG, CYP induction) to GLP in-vivo studies, delivering the IND-enabling toxicity package regulators require — now augmented by toxicogenomics and virtual control groups.</description></item></channel></rss>